{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:24:13Z","timestamp":1786947853523,"version":"build-2736575974"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Post-transplant malignancies (PTMs) remain major late immune-related complications after kidney transplantation, but long-term Asian data integrating immunologic exposures are limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed 1,808 kidney transplant recipients from 2002 to 2022 at Taichung Veterans General Hospital, Taiwan. After exclusions, 1,734 patients were eligible. Outcomes included PTM incidence, spectrum, latency, temporal trends, and survival, with prespecified analyses of longitudinal tacrolimus trough levels and cumulative immunosuppressive burden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      PTM incidence was 11.7%. Urothelial (bladder 15.8%, upper tract 14.3%) and liver cancers predominated. One third occurred within 5 years with a median latency of 8.2 years. Bladder cancer declined after 2012 (26.7%\n                      <jats:italic>vs<\/jats:italic>\n                      . 11.2%,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.010). Older age independently predicted PTM (HR 1.08 per year,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&amp;lt;\u00a00.001) and mortality (HR 1.07 per year,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&amp;lt;\u00a00.001). Higher long-term tacrolimus trough levels were independently associated with mortality in both the overall and PTM cohorts (HR 1.24 and 1.37, both p &amp;lt; 0.05). PTM patients had higher mortality (46.3%\n                      <jats:italic>vs<\/jats:italic>\n                      . 30.6%) with median post-diagnosis survival of 16.5 months.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>PTMs in Taiwan are frequent and immunologically shaped, with a distinct urothelial and hepatic predominance and a post 2012 decline in bladder cancer plausibly linked to evolving immunosuppression, surveillance, and reduced carcinogen exposure. Older age and cumulative immunosuppressive burden were associated with PTM development, whereas higher long-term tacrolimus trough levels independently predicted mortality, underscoring the need for individualized immunosuppressive management and cancer type specific surveillance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1738516","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T05:25:35Z","timestamp":1786944335000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Post-transplant malignancies in Taiwanese kidney transplant recipients: incidence, temporal trends, and immunosuppressive risk factors in a two-decade single-center cohort"],"prefix":"10.3389","volume":"17","author":[{"given":"Hsiang-Chen","family":"Hsieh","sequence":"first","affiliation":[{"name":"Institute of Medicine, Chung Shan Medical University","place":["Taichung, Taiwan"]},{"name":"Department of Urology, Taichung Veterans General Hospital","place":["Taichung, Taiwan"]},{"name":"Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University","place":["Taichung, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Ri","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Medicine, Chung Shan Medical University","place":["Taichung, Taiwan"]},{"name":"Department of Urology, Taichung Veterans General Hospital","place":["Taichung, Taiwan"]},{"name":"Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University","place":["Taichung, Taiwan"]},{"name":"Department of Medicine and Nursing, Hungkuang University","place":["Taichung, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shian Shiang","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute of Medicine, Chung Shan Medical University","place":["Taichung, Taiwan"]},{"name":"Department of Urology, Taichung Veterans General Hospital","place":["Taichung, Taiwan"]},{"name":"Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University","place":["Taichung, Taiwan"]},{"name":"Department of Applied Chemistry, National Chi Nan University","place":["Nantou, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-Shu","family":"Chen","sequence":"additional","affiliation":[{"name":"Institute of Medicine, Chung Shan Medical University","place":["Taichung, Taiwan"]},{"name":"Department of Urology, Taichung Veterans General Hospital","place":["Taichung, Taiwan"]},{"name":"Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University","place":["Taichung, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Kuang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Urology, Taichung Veterans General Hospital","place":["Taichung, Taiwan"]},{"name":"Department of Biological Science and Technology, National Yang Ming Chiao Tung University","place":["Hsinchu, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-Fa","family":"Yang","sequence":"additional","affiliation":[{"name":"Institute of Medicine, Chung Shan Medical University","place":["Taichung, Taiwan"]},{"name":"Department of Medical Research, Chung Shan Medical University Hospital","place":["Taichung, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03686.x","article-title":"Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes","volume":"11","author":"Tonelli","year":"2011","journal-title":"Am J Transplant"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-018-0022-6","article-title":"Cancer in kidney transplant recipients","volume":"14","author":"Au","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2004.00450.x","article-title":"Cancer after kidney transplantation in the United States","volume":"4","author":"Kasiske","year":"2004","journal-title":"Am J Transplant"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfac239","article-title":"Malignancies in adult kidney transplant candidates and recipients: current status","volume":"38","author":"Serkies","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2024.151494","article-title":"Epidemiology of cancer in kidney transplant recipients","volume":"44","author":"Massicotte-Azarniouch","year":"2024","journal-title":"Semin Nephrol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12882-022-02796-6","article-title":"Risk of malignancy in kidney transplant recipients: a nationwide population-based cohort study","volume":"26","author":"Jung","year":"2022","journal-title":"BMC Nephrol."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfx122","article-title":"Risk factors associated with post-kidney transplant Malignancies: an article from the Cancer-Kidney International Network","volume":"11","author":"Sprangers","year":"2018","journal-title":"Clin Kidney J"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.14570920","article-title":"De novo Malignancies after kidney transplantation","volume":"17","author":"Al-Adra","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among US solid organ transplant recipients","volume":"306","author":"Engels","year":"2011","journal-title":"JAMA"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfr277","article-title":"Malignancies after renal transplantation in Taiwan: a nationwide population-based study","volume":"27","author":"Li","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.6002\/ect.2019.0210","article-title":"De novo Malignancy after heart, kidney, and liver transplant: a nationwide study in Taiwan","volume":"18","author":"Yeh","year":"2020","journal-title":"Exp Clin Transplant"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-013-0544-6","article-title":"Epidemiology of post-transplant Malignancy in Asian renal transplant recipients: a population-based study","volume":"46","author":"Hsiao","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2004.03.016","article-title":"High cumulative incidence of urinary tract transitional cell carcinoma after kidney transplantation in Taiwan","volume":"43","author":"Wu","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2012.04209.x","article-title":"Malignancies after kidney transplantation: Hong Kong renal registry","volume":"12","author":"Cheung","year":"2012","journal-title":"Am J Transplant"},{"key":"B15","doi-asserted-by":"publisher","first-page":"21398","DOI":"10.1038\/s41598-020-78283-5","article-title":"Incidence of Malignancy and related mortality after kidney transplantation: a nationwide, population-based cohort study in Korea","volume":"10","author":"Jeong","year":"2020","journal-title":"Sci Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1186\/s12882-018-1110-3","article-title":"Cancer risk after renal transplantation in South Korea: a nationwide population-based study","volume":"19","author":"Heo","year":"2018","journal-title":"BMC Nephrol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0215(19970516)71:4<517::aid-ijc3>3.0.co;2-x","article-title":"Cancer risk after renal transplantation in Japan","volume":"71","author":"Hoshida","year":"1997","journal-title":"Int J Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2016.01.017","article-title":"Impact of mTOR inhibitors on cancer development in kidney transplantation recipients: a population-based study","volume":"48","author":"Kao","year":"2016","journal-title":"Transplant Proc"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1676","article-title":"Effect of mechanistic target of rapamycin inhibitors on postrenal transplantation Malignancy: a nationwide cohort study","volume":"7","author":"Hou","year":"2018","journal-title":"Cancer Med"},{"key":"B20","article-title":"Post-transplantation malignancy: a cell autonomous mechanism with implications for therapy","volume":"120","author":"Suthanthiran","year":"2009","journal-title":"Trans Am Clin Climatol Assoc."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1119920109","article-title":"Aristolochic acid-associated urothelial cancer in Taiwan","volume":"109","author":"Chen","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-022-00494-x","article-title":"Aristolochic acid-associated cancers: a public health risk in need of global action","volume":"22","author":"Das","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13058","article-title":"Relationship between arsenic-containing drinking water and skin cancers in the arseniasis endemic areas in Taiwan","volume":"43","author":"Cheng","year":"2016","journal-title":"J Dermatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.26859","article-title":"Gender differences in cancer risk after kidney transplantation","volume":"10","author":"Buxeda","year":"2019","journal-title":"Oncotarget"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-017-8648-x","article-title":"Sexual dimorphism in innate immunity","volume":"56","author":"Jaillon","year":"2019","journal-title":"Clin Rev Allergy Immunol"},{"key":"B27","first-page":"144","article-title":"Colorectal cancer after kidney transplantation: risks and implications for screening and early detection","volume":"5","author":"Wong","year":"2011","journal-title":"Transplant Rev"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.22.012703.104803","article-title":"The three Es of cancer immunoediting","volume":"22","author":"Dunn","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity\u2019s roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0180-1","article-title":"Mechanisms underlying T cell ageing","volume":"19","author":"Goronzy","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0047-6374(99)00010-X","article-title":"Immunosenescence: impact in the young as well as the old","volume":"108","author":"Pawelec","year":"1999","journal-title":"Mech Ageing Dev"},{"key":"B32","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/01.tp.0000081399.75231.3b","article-title":"Tacrolimus enhances transforming growth factor-beta1 expression and promotes tumor progression","volume":"76","author":"Maluccio","year":"2003","journal-title":"Transplantation"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.21037\/tau-22-138","article-title":"Carcinogenicity risk associated with tacrolimus use in kidney transplant recipients: a systematic review and meta-analysis","volume":"11","author":"Wang","year":"2022","journal-title":"Transl Androl Urol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-024-02597-8","article-title":"Tumorigenic role of tacrolimus through mTORC1\/C2 activation in post-transplant renal cell carcinomas","volume":"130","author":"Moldvai","year":"2024","journal-title":"Br J Cancer"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000203554.54242.56","article-title":"Myeloma, Hodgkin disease, and lymphoid leukemia after renal transplantation: characteristics, risk factors and prognosis","volume":"81","author":"Caillard","year":"2006","journal-title":"Transplantation"},{"key":"B36","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1097\/tp.0b013e318199c1c7","article-title":"Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation","volume":"87","author":"Opelz","year":"2009","journal-title":"Transplantation"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/med\/9780197697320.003.0001","article-title":"Long-term survival after kidney transplantation","volume":"385","author":"Hariharan","year":"2021","journal-title":"N Engl J Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2018090906","article-title":"Overall and site-specific cancer mortality in patients on dialysis and after kidney transplant","volume":"30","author":"Au","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.4285\/kjt.22.0013","article-title":"Immune checkpoint inhibitors for solid organ transplant recipients: clinical updates","volume":"36","author":"Kawashima","year":"2022","journal-title":"Korean J Transplant."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15811","article-title":"Efficacy and tolerance of immune checkpoint inhibitors in transplant patients with cancer: a systematic review","volume":"20","author":"d Izarny-Gargas","year":"2020","journal-title":"Am J Transplant"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.5301\/jo-n.5000006","article-title":"Immune checkpoint inhibitors in the cancer patient with an organ transplant","volume":"1","author":"Wanchoo","year":"2017","journal-title":"J Onco-Nephrol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1206759","DOI":"10.3389\/fimmu.2024.1372862","article-title":"Immune modulation in transplant medicine: a comprehensive review of cell therapy applications and future directions","volume":"15","author":"Knoedler","year":"2024","journal-title":"Front Immunol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1738516\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T05:25:37Z","timestamp":1786944337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1738516\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":42,"alternative-id":["10.3389\/fimmu.2026.1738516"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1738516","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"article-number":"1738516"}}